tm logo
MABLINK
Live/Registered
REGISTERED

on 26 Oct 2021

Last Applicant/ Owned by

F-69006 LYON

FR

Serial Number

79299550 filed on 15th Jul 2020

Registration Number

6532856 registered on 26th Oct 2021

in the Principal Register

Correspondent Address

John R. Rudolph

John R. Rudolph Eli Lilly and Company

Indianapolis, IN 46285

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

MABLINK

Scientific research; biological and chemical research; biochemical research and development; research and development in the pharmaceutical, biomedical and biotechnological fields, namely, research into antibodies, including conjugated antibodies; research and development in the fields of biological development and biomanufacturing; laboratory research, analysis, evaluation, development and clinic Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Medical services; medical services, namely, medical modification of antibodies; medical services in the field of personalized medicine; medical advice and information services in the field of biopharmaceutical products; pharmaceutical advice; consultancy services in the field of medicine


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [042]
Computer & Software Services & Scientific Services


Scientific research; biological and chemical research; biochemical research and development; research and development in the pharmaceutical, biomedical and biotechnological fields, namely, research into antibodies, including conjugated antibodies; research and development in the fields of biological development and biomanufacturing; laboratory research, analysis, evaluation, development and clinical testing of therapeutic, preventive and diagnostic compositions and treatments; conducting scientific and medical research for third parties in the field of pharmaceuticals and cancer therapy ; consultancy in the field of pharmaceutical research, chemistry, biotechnology; Performance of chemical analyses, namely, custom synthesis of chemical substances; chemical and biological development services, namely custom design and development of chemical reagents and biochemical assays; services of a chemist and a biologist; scientific laboratory services namely chemical and biological laboratory services; scientific laboratory services, namely, laboratory services concerning the modification and production of reagents, antibodies and conjugated antibodies; scientific research and development services in the field of reagent development and production of antibodies and conjugated antibodies; conducting chemical and biological analyses; customized design and development of chemical reagents, antibodies and conjugated antibodies; development of chemical substances, namely, chemical substances to tether molecules and in particular technological platforms for the creation or improvement of antibody-drug conjugates or any protein combined with a drug, a polynucleotide, another protein, a chemical entity or another functional entity intended for industry and science


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of cancer ; pharmaceutical products for the prevention or treatment of human diseases, namely, the treatment of cancer; chemical, biological and biochemical products for medical and pharmaceutical use, namely, antibody-drug conjugates and any protein combined with a drug, a polynucleotide, another protein, a chemical entity, or another functional entity, and used as medical binders or fillers; pharmaceutical preparations, namely bioconjugates, intended for the diagnosis and treatment of diseases, namely, cancer ; antibody products, namely, antibody or protein bioconjugates for the medical diagnosis and treatment of cancer, namely, antibody/protein drug conjugates, antibody/protein labeled conjugates and antibody/protein imaging agent conjugates; delivery devices for antibodies, namely, drugs delivery agent in the form of antibodies drug conjugates that facilitate the delivery and action of medical preparations ; molecules and biomolecules, namely, reagents, antibody fragments, antibodies, all intended for medical diagnosis and disease treatment; pharmaceutical products, preparations and medical articles, namely, antibodies, antibody conjugates and active principles and antibody conjugates for medical purposes; chemical reagents for medical use, namely, chemical reagents to bind molecules for medical use; chemical reagents for the functionalization of biomolecules for medical use


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products


Chemical, biochemical, biological and biotechnological preparations for use in industry and science ; chemical substances for the manufacture of pharmaceutical products for non-medical purposes, namely, for use in manufacturing of antibody conjugates ; chemical substances for tethering molecules, in particular chemical substances for tethering molecules for cancer therapy, for research in active substances and medicines other than for medical or veterinary purposes; chemical substances for the formation of antibody conjugates for use in laboratories, other than for medical or veterinary purposes ; chemical reagents for scientific purposes other than for medical or veterinary purposes; reagents for scientific or medical research; chemical, biochemical and biological reagents for scientific or medical research use; chemicals for bioconjugation, reversible cysteine protection, surface modification, and the production of prodrugs for use in laboratories, other than for medical or veterinary purposes; antibodies and antibody conjugates for scientific purposes, other than for medical or veterinary purposes; antibodies for scientific or medical research; molecules and biomolecules, namely, reagents, antibody fragments, antibodies, all intended for fundamental research and development, medical research and scientific diagnosis; Diagnostic products for scientific or research use related to conjugated antibodies, namely, diagnostic preparations for scientific use


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [040]
Treatment & Processing of Materials Services


Preparation, transformation, processing of biopharmaceutical materials, reagents, antibodies and conjugated antibodies, namely, biomanufacturing for others, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process; processing and transformation of biopharmaceuticals on behalf of third parties; custom manufacturing of scientific, medical, chemical, biochemical and pharmaceutical products, namely, conjugated antibodies and drug conjugate by biopharmaceutical compounders


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79299550

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
28th Apr 2024NEW REPRESENTATIVE AT IB RECEIVED
14th Mar 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14th Mar 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
14th Mar 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14th Mar 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
14th Mar 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09th May 2022FINAL DECISION TRANSACTION PROCESSED BY IB
18th Apr 2022FINAL DISPOSITION NOTICE SENT TO IB
18th Apr 2022FINAL DISPOSITION PROCESSED
26th Jan 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB